Abnormalities in serum copper and iron concentrations in porphyria cutanea tarda patients and their relationships with other parameters.
作者信息
Dabrowska E, Jabłońska-Kaszewska I, Lukasiak J, Dorosz A, Falkiewicz B
机构信息
III Department of Internal Medicine, Medical University of Gdańsk, Poland.
出版信息
Biofactors. 2000;11(1-2):135-7. doi: 10.1002/biof.5520110140.
PMID:10705985
Abstract
摘要
相似文献
1
Abnormalities in serum copper and iron concentrations in porphyria cutanea tarda patients and their relationships with other parameters.
Biofactors. 2000;11(1-2):135-7. doi: 10.1002/biof.5520110140.
2
Serum iron and copper and their relations to hepatocellular carcinoma in porphyria cutanea tarda and hemochromatosis patients--case report.
Biofactors. 2000;11(1-2):131-4. doi: 10.1002/biof.5520110139.
3
Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda.
Hepatology. 1993 Apr;17(4):551-7. doi: 10.1002/hep.1840170405.
4
Iron and porphyria cutanea tarda.
Cell Mol Biol (Noisy-le-grand). 1997 Feb;43(1):75-9.
5
[Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Ann Dermatol Venereol. 2001 May;128(5):600-4.
6
The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
J Hepatol. 1995 Sep;23(3):259-67.
7
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
Hepatology. 1992 Dec;16(6):1322-6. doi: 10.1002/hep.1840160603.
8
[Effect of chloroquine treatment of porphyria cutanea tarda on the associated liver disease].
Rev Invest Clin. 2000 Mar-Apr;52(2):211-3.
9
Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
Acta Derm Venereol. 2003;83(2):115-20. doi: 10.1080/00015550310007454.
10
Generalized morphoea secondary to porphyria cutanea tarda.
Br J Dermatol. 1993 Oct;129(4):455-7. doi: 10.1111/j.1365-2133.1993.tb03176.x.
Zotero 插件